600771 GuangYuYuan Chinese Herbal Medicine
- 16.70
- -0.15-0.89%
GuangYuYuan Chinese Herbal Medicine News
Guangyuyuan Traditional Chinese Medicine Co., Ltd. Investor Relations Activity Record Form (2024 Semi-Annual Report Results Briefing)
Announcement of Guangyuyuan Traditional Chinese Medicine Co., Ltd. on the controlling shareholder\'s initial increase in the company\'s shares and subsequent plans to increase its holdings
Notice of Guangyuyuan Traditional Chinese Medicine Co., Ltd. on holding the 2024 semi-annual results briefing
Guangyuyuan Chinese Herbal Medicine Co., Ltd.'s 2023 Environmental, Social, and Governance (ESG) Report
Guangyuyuan Chinese Herbal Medicine Co., Ltd. 2024 Semi-annual Report
Summary of Guangyuyuan Chinese Herbal Medicine Co., Ltd.'s 2024 Interim Report
Announcement of the resolution of the ninth meeting of the eighth board of supervisors of Guangyuyuan Chinese Herbal Medicine Co., Ltd.
Announcement of the resolution of the 11th meeting of the 8th Board of Directors of Guangyuyuan Chinese Herbal Medicine Co., Ltd.
Announcement of resolutions of the 2023 Annual Shareholder's Meeting of Guangyuyuan Chinese Herbal Medicine Co., Ltd.
Legal Opinion of Hai Run Tian Rui Law Firm on Guang Yu Yuan Traditional Chinese Medicine Co., Ltd.'s 2023 Annual Shareholders Meeting
Guangyuyuan Chinese Herbal Medicine Co., Ltd. Announces the Progress of Performance Commitments and Major Litigation Matters in the Previous Major Asset Restructuring Target Company.
Guangyuyuan Chinese Herbal Medicine Co., Ltd.'s 2023 Annual Shareholders Meeting Document
Reply from Ernst & Young Zhonghe Certified Public Accountants (Special General Partnership) regarding the Information Disclosure and Supervision Letter on the Annual Report of Guangyuyuan Chinese Herbal Medicine Co., Ltd. for the year 2023.
Orient, the underwriter and sponsor of Guangyuyuan Chinese Herbal Medicine Co., Ltd., has provided feedback on the regulatory compliance of the annual report information disclosure in 2023.
Guangyuyuan Chinese Herbal Medicine Co., Ltd.'s reply to the Shanghai Stock Exchange's regulatory work letter on the company's 2023 annual report information disclosure.
Orient Securities Underwriting and Sponsorship Co., Ltd.'s verification opinion on the performance commitment, asset impairment, and compensation of the purchase of assets and fund raising by Guangyuyuan Traditional Chinese Medicine Co., Ltd. through the issuance of shares and related transactions.
Announcement on the progress of performance commitments by the target company in the previous major asset restructuring of Guangyuyuan Chinese Herbal Medicine Co., Ltd.
Announcement of resolutions of the 10th meeting of the 8th Board of Directors of Guangyuyuan Chinese Herbal Medicine Co., Ltd.
Statement and Commitment of Independent Director Candidate (Wang Jijun)
Statement and Commitment of Independent Director Nominee (Board of Directors nominates Wang Jijun)
Analysis
Price Target
No Data
